tiprankstipranks
Maravai Lifesciences Holdings (MRVI)
NASDAQ:MRVI
US Market

Maravai Lifesciences Holdings (MRVI) Income Statement

Compare
379 Followers

Maravai Lifesciences Holdings Income Statement

Last quarter (Q3 2024), Maravai Lifesciences Holdings's total revenue was $65.20M, a decrease of -2.49% from the same quarter last year. In Q3, Maravai Lifesciences Holdings's net income was $-99.04M. See Maravai Lifesciences Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 288.94M$ 883.00M$ 799.24M$ 284.10M$ 143.14M
Gross Profit
$ 140.20M$ 714.04M$ 658.68M$ 204.45M$ 76.29M
Operating Expenses
$ 171.85M$ 147.63M$ 115.28M$ 103.55M$ 51.98M
Depreciation and Amortization
$ 48.78M$ 38.10M$ 24.75M$ 25.84M$ 24.08M
EBITDA
$ 712.41M$ 609.99M$ 585.78M$ 138.27M$ 48.19M
Operating Income
$ -31.65M$ 574.22M$ 554.64M$ 67.60M$ 23.99M
Other Income/Expenses
$ 649.38M$ -22.74M$ -23.88M$ -22.09M$ -29.84M
Pretax Income
$ 617.74M$ 551.47M$ 530.76M$ 81.70M$ -5.85M
Net Income
$ -119.03M$ 490.66M$ 469.25M$ 76.89M$ -5.20M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.90$ 3.73$ 4.09$ 0.80$ -0.05
Diluted EPS
$ -0.90$ 1.92$ 1.82$ 0.70$ -0.05
Weighted Average Shares Outstanding
131.92M 131.54M 114.79M 96.65M 96.65M
Weighted Average Shares Outstanding (Diluted)
131.92M 255.32M 257.80M 96.65M 96.65M
Currency in USD

Maravai Lifesciences Holdings Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis